Arrangement - Side 5

Dr. Matti Nykter, Professor at the Tampere University, Finland, will present the lecture "Computational analysis to understand aberrant gene expression and treatment induced responses in prostate cancer."

To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.

Dr. Colm Ryan, Assistant Professor at the University College Dublin, will present the lecture "Identifying robust genetic interactions in cancer."

Forming a business partnership can be beneficial or even vital to obtain success, but it has to be done correctly. If not, it can be catastrophic. Learn more about what it takes to secure a successful partnering and finance setup. What are the pitfalls? What is critical? What are the dos and don'ts?

Procedures that work in the lab don¡¯t always scale-up seamlessly into production in the life science industry. Process development while staying compliant will be required. What should be considered when you work in lab-scale to make the transition to production smoother? What are the common pitfalls, and what are the dos and don¡¯ts?

Dr. Tero Aittokallio, Professor at the Oslo Centre for Biostatistics and Epidemiology and Group Leader at the Institute for Cancer Research, Oslo, Norway, will present his lecture "Predictive modelling of drug combination effects for precision medicine."

Vi feirer 50-?rsdagen for Odd Hassels Nobelpris i kjemi: Program og p?melding til Hassel-seminaret 31. oktober til og med 1. november. 

This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.

Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?

We are pleased to announce that Dr. Adam Novak will be the guest speaker of our upcoming Sven Furberg Seminar in Bioinformatics and Statistical Genomics on the coming Friday, Sep 27, at 14:30 in Lille auditorium, Kristen Nygaards hus.

Dr. Adam Novak, senior software engineer in the UCSC Genomics Institute, will present his lecture "Graph-based genome representations".

Abstract:

Graph-based approaches to genomics problems can beat out traditional linear-reference-based tools, reducing reference allele bias and improving structural variant calling. For these reasons and others, graph genomics techniques are becoming more popular, and more graph-based tools are being developed. Here I present lessons on genome graph API design learned during the development of the vg variation graph toolkit. I show how techniques and libraries extracted from vg can be used to help developers quickly bootstrap new graph-based projects, forming an ecosystem of interoperable graph genomics tools.

UiO satser stort p? livsvitenskap og ?nsker ? bidra til ny helsen?ring. Thermo Fisher Scientific er ett av firmaene som har lykkes med ? ta norske forskningsresultater videre til anvendelse over hele verden, samtidig som de har bevart aktivitet i Norge. Hva ser de etter hos studenter fra UiO, og hva kan de tilby? M?t ogs? en ung forsker fra UiO:Livsvitenskaps innovasjonsprogram SPARK Norway.

Skal universitetet spille en rolle i ? l?se klimakrisen? Hvilken effekt har skolestreikene? M? professorer fly, og hvordan skal vi utdanne fremtidige studenter til et b?rekraftig arbeidsliv? Vi tar debattene p? Kulturhuset.

Hvorfor er medisinske forskere opptatt av torsken? Har du h?rt lyden av torsk? Test dine kunnskaper i den store torskequizen og vinn fine premier.

Hva skulle vi gjort uten havet? Bli med p? en bevisstgj?rende frokost med forskere fra UiO og kunstnere. Vi dypdykker ned i det m?rke, store bl? og f?r myter knust og fakta formidlet.

A part of Nordic Life Science Awards that features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients.

Clinical trials are essential to develop new treatments. What are the fundamental issues that must be considered when designing clinical trials? What are the pitfalls? What are the dos and don¡¯ts?

The UiO:Life Science ImmunoLingo Convergence Environment Symposium.

The scope of the workshop: This international workshop brings together scientist from a wide range of fields with a special interest in bio-mechanics phenomena from cellular scale to the size of organs. Through a series of short talks the participants will present their work, where the workshop strives to stimulate scientific exchange and to initiate new collaborations.

P? tide med ny mobil, eller kan du bruke den gamle litt lenger? Norge ligger p? verdenstoppen i produksjon av elektronisk avfall. Milj?giftene fra avfallet fordeler seg i milj?et og tas opp i planter og dyr. Hvordan m? vi jobbe lokalt, nasjonalt og internasjonalt for ? f? bukt med problemet? Hvordan kan politikere og forbrukere bidra til gode l?sninger?

Patent strategy is an important part of the innovation process. On this seminar you will hear from experts from Inven2 and learn how you can build a solid patent strategy.

Dr. Mark Robinson, Associate Professor of Statistical Genomics, Institute of Molecular Life Sciences, University of Zurich, Switzerland, will present his lecture "Statistical methods for flexible differential analysis of multi-sample multi-condition single-cell RNA-seq datasets."

Bli kjent med det nye digitale l?ringsuniverset i bioteknologi og livsvitenskap. Temaene er knyttet opp mot sentrale kompetansem?l i naturfag, samfunnsfag og KRLE, og egner seg godt for tverrfaglig arbeid.

Solid research is the basis for all new innovations. However, too often data generated in academia turns out to be irreproducible by others and therefor fail in translation to new products and treatments. What does it take to achieve reproducible high quality data?

Dr. G¨¹nter Klambauer, Institute for Bioinformatics, Johannes Kepler University Linz, Austria, will present the lecture "Deep Learning methods in early-stage drug discovery."